In the United States, Pfizer’s revenue was further hit by the loss of exclusivity of high chlorestorol medication, Lipitor (atorvastatin calcium), when its patent ran out in November 2011.

Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

In December 2006, when Pfizer reported the mortality of cardiovascular patients in a phase 3 trial receiving torcetrapib and atorvastatin was greater than that of patients receiving atorvastatin ...

According to West Virginia Attorney General Patrick Morrisey, a $17 million settlement between the state, Pfizer, and Ranbaxy has been approved. The antitrust lawsuit involved a generic, cheaper ...

Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which spells big savings for many of the 8.7 million Americans who take the medication. The patent’s expiration ...

It alleged that Pfizer Inc. and Ranbaxy Inc. delayed the production of a cheaper version of the cholesterol-lowering drug Lipitor. West Virginia received a total of $3,485,000 from the settlement.

Pfizer is known for making blockbuster drugs Viagra and Lipitor. Here's the story of how Allergan went from a small Los Angeles company known for making eye-drops to an Ireland-domiciled drug ...